+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Rotavirus Vaccine Market - Global Forecast 2026-2032- Product Image
Rotavirus Vaccine Market - Global Forecast 2026-2032- Product Image
Sale

Rotavirus Vaccine Market - Global Forecast 2026-2032

  • Report

  • 199 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6123524
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Rotavirus Vaccine Market is projected to reach USD 4.44 Billion in 2026. It is expected to continue growing at a CAGR of 6.85%, reaching USD 6.56 Billion by 2032.

Rotavirus Vaccine Market: Executive Summary

Rotavirus vaccination remains a core public-health intervention for preventing severe diarrheal disease in infants and young children. Its impact depends on timely administration, sustained immunization-system performance, reliable product quality, and equitable access across routine and catch-up programs. Policy priorities increasingly center on reducing missed doses, strengthening cold-chain and delivery infrastructure, and maintaining confidence in childhood vaccination.

Delivery Systems Are Reshaping Rotavirus Immunization

The landscape is being transformed by integration with routine infant immunization, expanded outreach, improved supply planning, and greater attention to underserved communities. Health authorities are using electronic registries, reminder systems, community health workers, and coordinated primary-care services to improve completion of multi-dose schedules. Product handling, age-window compliance, safety monitoring, and procurement resilience remain operational priorities, particularly where health systems face workforce, logistics, or financing constraints.

Artificial Intelligence Supports Targeting, Planning, and Safety Oversight

Artificial intelligence can strengthen rotavirus-vaccine programs by identifying children at risk of missed doses, optimizing clinic and outreach planning, and improving demand and inventory visibility. Machine-learning tools may also help detect unusual safety signals when linked with robust pharmacovigilance systems. These applications require representative data, privacy safeguards, human review, transparent validation, and alignment with public-health governance; AI should support-not replace-clinical and immunization professionals.

Regional Priorities Span Access, Equity, and Program Resilience

In North America, priorities include maintaining high routine coverage, addressing pockets of hesitancy, and improving access among mobile and underserved families. Latin America continues to emphasize equitable primary-care delivery, reliable procurement, and protection of routine services during disruptions. Europe focuses on differing national schedules, safety communication, and closing subnational coverage gaps. The Middle East requires resilient services for displaced and conflict-affected populations, while Africa places strong emphasis on financing, cold-chain capacity, workforce reach, and integration with broader child-health programs. Asia-Pacific combines large and diverse birth cohorts with varied delivery systems, making locally adapted outreach, supply planning, and equity strategies essential.

Group-Level Dynamics Shape Coordination and Access

ASEAN members benefit from regional cooperation on procurement, surveillance, and immunization-system strengthening while adapting schedules to national contexts. BRICS countries bring substantial manufacturing, delivery, and research capabilities but face differing burdens, geographies, and access constraints. Within the European Union, coordination on evidence, safety, and cross-border public-health resilience complements national program decisions. The G7 can support financing, innovation, and global health-system resilience. GCC states generally have strong clinical infrastructure but must sustain coverage among migrant and mobile populations. NATO members must account for continuity of essential immunization during emergencies, displacement, and infrastructure disruption.

Country Contexts Require Tailored Program Execution

Australia and Canada must sustain geographically inclusive delivery across remote communities. Brazil and Mexico benefit from strong public-health platforms while continuing to address regional inequities and service interruptions. China and India require extensive coordination across diverse provincial and state systems, with emphasis on reliable supply and timely infant vaccination. France, Germany, Italy, Spain, and the United Kingdom must manage national policy variation, confidence, and localized gaps within mature health systems. Japan and South Korea emphasize schedule adherence, safety communication, and integration with well-developed pediatric care. Russia faces the need to preserve continuity, surveillance, and access across a geographically expansive system. In the United States, program performance depends on provider engagement, affordability and access pathways, and targeted action in communities with lower uptake.

Actions for Leaders: Strengthen Coverage, Resilience, and Trust

Industry and public-health leaders should prioritize dependable supply and cold-chain operations, transparent quality systems, and evidence-based support for routine immunization providers. Programs should use disaggregated coverage data to identify missed-dose and zero-dose populations, then pair digital reminders with community-based outreach. Leaders should reinforce pharmacovigilance, communicate benefits and risks clearly, and prepare continuity plans for emergencies. Responsible AI pilots should begin with defined use cases, measurable outcomes, data-protection controls, and clinician oversight. Cross-sector coordination can align procurement, delivery, surveillance, and caregiver education around practical barriers to timely vaccination.

Methodology: Evidence-Led Synthesis of Program and Policy Drivers

This executive summary uses a structured qualitative synthesis focused on rotavirus-vaccine access, delivery, safety, policy, technology, and health-system factors. The assessment organizes implications across the specified regions, country groupings, and countries, emphasizing publicly verifiable public-health principles and documented program considerations. It excludes market estimates, market shares, forecasts, and company-specific claims. Findings are framed as strategic themes rather than quantified commercial conclusions and should be validated against current national schedules, regulatory decisions, surveillance reports, and immunization-program data.

Conclusion: Embed Rotavirus Vaccination in Resilient Child Health Systems

Rotavirus vaccination delivers its greatest public-health value when it is timely, routine, trusted, and accessible to every eligible child. Regional and national differences make adaptable delivery essential, while AI and digital tools offer practical support for targeting and program management when governed responsibly. Sustained leadership should focus on equity, dependable supply, high-quality surveillance, caregiver confidence, and continuity of services so that immunization gains remain durable across changing health-system conditions.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Rotavirus Vaccine Market, by Vaccine Type
7.1. Introduction
7.2. Inactivated
7.3. Live Attenuated Oral
8. Rotavirus Vaccine Market, by Presentation
8.1. Introduction
8.2. Liquid
8.2.1. Multi-dose Vial
8.2.2. Prefilled Syringes
8.3. Lyophilized
8.3.1. Multi-dose Vial
8.3.2. Single-dose Vial
9. Rotavirus Vaccine Market, by Distribution Channel
9.1. Introduction
9.2. Clinics
9.3. Hospital Pharmacies
9.4. Online Pharmacies
9.5. Retail Pharmacies
10. Rotavirus Vaccine Market, by End User
10.1. Introduction
10.2. Clinics
10.2.1. General Clinics
10.2.2. Pediatric Clinics
10.3. Community Health Centers
10.3.1. Hospital Based
10.3.2. Standalone
10.4. Hospitals
10.4.1. Private Hospitals
10.4.2. Public Hospitals
11. Rotavirus Vaccine Market, by Region
11.1. Introduction
11.2. Asia-Pacific
11.3. North America
11.4. Latin America
11.5. Europe
11.6. Middle East
11.7. Africa
12. Rotavirus Vaccine Market, by Group
12.1. Introduction
12.2. ASEAN
12.3. GCC
12.4. European Union
12.5. BRICS
12.6. G7
12.7. NATO
13. Rotavirus Vaccine Market, by Country
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. United Kingdom
13.7. Germany
13.8. France
13.9. Russia
13.10. Italy
13.11. Spain
13.12. China
13.13. India
13.14. Japan
13.15. Australia
13.16. South Korea
14. Competitive Landscape
14.1. Market Share Analysis, 2025
14.2. Market Concentration Analysis, 2025
14.2.1. Concentration Ratio (CR)
14.2.2. Herfindahl Hirschman Index (HHI)
14.3. Recent Developments & Impact Analysis, 2025
14.4. Product Portfolio Analysis, 2025
14.5. Benchmarking Analysis, 2025
15. Company Profiles
15.1. Bharat Biotech International Limited
15.2. Bio Farma
15.3. Biological E. Limited
15.4. Cadila Healthcare Limited
15.5. GlaxoSmithKline plc
15.6. Hilleman Laboratories
15.7. Indian Immunologicals Limited
15.8. Lanzhou Institute of Biological Products Co., Ltd.
15.9. Merck & Co., Inc.
15.10. Novavax, Inc.
15.11. Panacea Biotec Ltd.
15.12. Pfizer Inc.
15.13. Sanofi S.A.
15.14. Serum Institute of India Pvt. Ltd.
15.15. Shantha Biotechnics
15.16. Sinovac Biotech Ltd.
15.17. Takeda Pharmaceutical Company Limited
15.18. Valneva SE
16. Key Experts
LIST OF FIGURES
FIGURE 1. Global Rotavirus Vaccine Market, Years Considered for the Study
FIGURE 2. Global Rotavirus Vaccine Market, Research Design
FIGURE 3. Global Rotavirus Vaccine Market, Research Framework
FIGURE 4. Global Rotavirus Vaccine Market, Data Triangulation
FIGURE 5. Global Rotavirus Vaccine Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Rotavirus Vaccine Market Size, by Vaccine Type, 2025 vs 2032 (%)
FIGURE 7. Global Rotavirus Vaccine Market Size, by Vaccine Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Rotavirus Vaccine Market Size, by Presentation, 2025 vs 2032 (%)
FIGURE 9. Global Rotavirus Vaccine Market Size, by Presentation, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Rotavirus Vaccine Market Size, by Distribution Channel, 2025 vs 2032 (%)
FIGURE 11. Global Rotavirus Vaccine Market Size, by Distribution Channel, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Rotavirus Vaccine Market Size, by End User, 2025 vs 2032 (%)
FIGURE 13. Global Rotavirus Vaccine Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Rotavirus Vaccine Market Size, by Region, 2025 vs 2032 (%)
FIGURE 15. Global Rotavirus Vaccine Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Rotavirus Vaccine Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 17. Global Rotavirus Vaccine Market Size, by Country, 2025 vs 2032 (%)
FIGURE 18. Global Rotavirus Vaccine Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global Rotavirus Vaccine Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Rotavirus Vaccine Market Segmentation & Coverage
TABLE 2. Global Rotavirus Vaccine Market Size, 2017-2032 (USD Million)
TABLE 3. Global Rotavirus Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 4. Global Inactivated Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Inactivated Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Inactivated Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Live Attenuated Oral Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Live Attenuated Oral Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Live Attenuated Oral Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Rotavirus Vaccine Market Size, by Presentation, 2017-2032 (USD Million)
TABLE 11. Global Liquid Market Size, by Region, 2017-2032 (USD Million)
TABLE 12. Global Liquid Market Size, by Group, 2017-2032 (USD Million)
TABLE 13. Global Liquid Market Size, by Country, 2017-2032 (USD Million)
TABLE 14. Global Multi-dose Vial Market Size, by Region, 2017-2032 (USD Million)
TABLE 15. Global Multi-dose Vial Market Size, by Group, 2017-2032 (USD Million)
TABLE 16. Global Multi-dose Vial Market Size, by Country, 2017-2032 (USD Million)
TABLE 17. Global Prefilled Syringes Market Size, by Region, 2017-2032 (USD Million)
TABLE 18. Global Prefilled Syringes Market Size, by Group, 2017-2032 (USD Million)
TABLE 19. Global Prefilled Syringes Market Size, by Country, 2017-2032 (USD Million)
TABLE 20. Global Lyophilized Market Size, by Region, 2017-2032 (USD Million)
TABLE 21. Global Lyophilized Market Size, by Group, 2017-2032 (USD Million)
TABLE 22. Global Lyophilized Market Size, by Country, 2017-2032 (USD Million)
TABLE 23. Global Multi-dose Vial Market Size, by Region, 2017-2032 (USD Million)
TABLE 24. Global Multi-dose Vial Market Size, by Group, 2017-2032 (USD Million)
TABLE 25. Global Multi-dose Vial Market Size, by Country, 2017-2032 (USD Million)
TABLE 26. Global Single-dose Vial Market Size, by Region, 2017-2032 (USD Million)
TABLE 27. Global Single-dose Vial Market Size, by Group, 2017-2032 (USD Million)
TABLE 28. Global Single-dose Vial Market Size, by Country, 2017-2032 (USD Million)
TABLE 29. Global Rotavirus Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 30. Global Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 31. Global Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 32. Global Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 33. Global Hospital Pharmacies Market Size, by Region, 2017-2032 (USD Million)
TABLE 34. Global Hospital Pharmacies Market Size, by Group, 2017-2032 (USD Million)
TABLE 35. Global Hospital Pharmacies Market Size, by Country, 2017-2032 (USD Million)
TABLE 36. Global Online Pharmacies Market Size, by Region, 2017-2032 (USD Million)
TABLE 37. Global Online Pharmacies Market Size, by Group, 2017-2032 (USD Million)
TABLE 38. Global Online Pharmacies Market Size, by Country, 2017-2032 (USD Million)
TABLE 39. Global Retail Pharmacies Market Size, by Region, 2017-2032 (USD Million)
TABLE 40. Global Retail Pharmacies Market Size, by Group, 2017-2032 (USD Million)
TABLE 41. Global Retail Pharmacies Market Size, by Country, 2017-2032 (USD Million)
TABLE 42. Global Rotavirus Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 43. Global Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 44. Global Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 45. Global Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 46. Global General Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 47. Global General Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 48. Global General Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 49. Global Pediatric Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 50. Global Pediatric Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 51. Global Pediatric Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 52. Global Community Health Centers Market Size, by Region, 2017-2032 (USD Million)
TABLE 53. Global Community Health Centers Market Size, by Group, 2017-2032 (USD Million)
TABLE 54. Global Community Health Centers Market Size, by Country, 2017-2032 (USD Million)
TABLE 55. Global Hospital Based Market Size, by Region, 2017-2032 (USD Million)
TABLE 56. Global Hospital Based Market Size, by Group, 2017-2032 (USD Million)
TABLE 57. Global Hospital Based Market Size, by Country, 2017-2032 (USD Million)
TABLE 58. Global Standalone Market Size, by Region, 2017-2032 (USD Million)
TABLE 59. Global Standalone Market Size, by Group, 2017-2032 (USD Million)
TABLE 60. Global Standalone Market Size, by Country, 2017-2032 (USD Million)
TABLE 61. Global Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 62. Global Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 63. Global Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 64. Global Private Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 65. Global Private Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 66. Global Private Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 67. Global Public Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 68. Global Public Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 69. Global Public Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 70. Global Rotavirus Vaccine Market Size, by Region, 2017-2032 (USD Million)
TABLE 71. Asia-Pacific Rotavirus Vaccine Market Size, by Region, 2017-2032 (USD Million)
TABLE 72. Asia-Pacific Rotavirus Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 73. Asia-Pacific Rotavirus Vaccine Market Size, by Presentation, 2017-2032 (USD Million)
TABLE 74. Asia-Pacific Rotavirus Vaccine Market Size, by Liquid, 2017-2032 (USD Million)
TABLE 75. Asia-Pacific Rotavirus Vaccine Market Size, by Lyophilized, 2017-2032 (USD Million)
TABLE 76. Asia-Pacific Rotavirus Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 77. Asia-Pacific Rotavirus Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 78. Asia-Pacific Rotavirus Vaccine Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 79. Asia-Pacific Rotavirus Vaccine Market Size, by Community Health Centers, 2017-2032 (USD Million)
TABLE 80. Asia-Pacific Rotavirus Vaccine Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 81. North America Rotavirus Vaccine Market Size, by Region, 2017-2032 (USD Million)
TABLE 82. North America Rotavirus Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 83. North America Rotavirus Vaccine Market Size, by Presentation, 2017-2032 (USD Million)
TABLE 84. North America Rotavirus Vaccine Market Size, by Liquid, 2017-2032 (USD Million)
TABLE 85. North America Rotavirus Vaccine Market Size, by Lyophilized, 2017-2032 (USD Million)
TABLE 86. North America Rotavirus Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 87. North America Rotavirus Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 88. North America Rotavirus Vaccine Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 89. North America Rotavirus Vaccine Market Size, by Community Health Centers, 2017-2032 (USD Million)
TABLE 90. North America Rotavirus Vaccine Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 91. Latin America Rotavirus Vaccine Market Size, by Region, 2017-2032 (USD Million)
TABLE 92. Latin America Rotavirus Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 93. Latin America Rotavirus Vaccine Market Size, by Presentation, 2017-2032 (USD Million)
TABLE 94. Latin America Rotavirus Vaccine Market Size, by Liquid, 2017-2032 (USD Million)
TABLE 95. Latin America Rotavirus Vaccine Market Size, by Lyophilized, 2017-2032 (USD Million)
TABLE 96. Latin America Rotavirus Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 97. Latin America Rotavirus Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 98. Latin America Rotavirus Vaccine Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 99. Latin America Rotavirus Vaccine Market Size, by Community Health Centers, 2017-2032 (USD Million)
TABLE 100. Latin America Rotavirus Vaccine Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 101. Europe Rotavirus Vaccine Market Size, by Region, 2017-2032 (USD Million)
TABLE 102. Europe Rotavirus Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 103. Europe Rotavirus Vaccine Market Size, by Presentation, 2017-2032 (USD Million)
TABLE 104. Europe Rotavirus Vaccine Market Size, by Liquid, 2017-2032 (USD Million)
TABLE 105. Europe Rotavirus Vaccine Market Size, by Lyophilized, 2017-2032 (USD Million)
TABLE 106. Europe Rotavirus Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 107. Europe Rotavirus Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 108. Europe Rotavirus Vaccine Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 109. Europe Rotavirus Vaccine Market Size, by Community Health Centers, 2017-2032 (USD Million)
TABLE 110. Europe Rotavirus Vaccine Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 111. Middle East Rotavirus Vaccine Market Size, by Region, 2017-2032 (USD Million)
TABLE 112. Middle East Rotavirus Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 113. Middle East Rotavirus Vaccine Market Size, by Presentation, 2017-2032 (USD Million)
TABLE 114. Middle East Rotavirus Vaccine Market Size, by Liquid, 2017-2032 (USD Million)
TABLE 115. Middle East Rotavirus Vaccine Market Size, by Lyophilized, 2017-2032 (USD Million)
TABLE 116. Middle East Rotavirus Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 117. Middle East Rotavirus Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 118. Middle East Rotavirus Vaccine Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 119. Middle East Rotavirus Vaccine Market Size, by Community Health Centers, 2017-2032 (USD Million)
TABLE 120. Middle East Rotavirus Vaccine Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 121. Africa Rotavirus Vaccine Market Size, by Region, 2017-2032 (USD Million)
TABLE 122. Africa Rotavirus Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 123. Africa Rotavirus Vaccine Market Size, by Presentation, 2017-2032 (USD Million)
TABLE 124. Africa Rotavirus Vaccine Market Size, by Liquid, 2017-2032 (USD Million)
TABLE 125. Africa Rotavirus Vaccine Market Size, by Lyophilized, 2017-2032 (USD Million)
TABLE 126. Africa Rotavirus Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 127. Africa Rotavirus Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 128. Africa Rotavirus Vaccine Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 129. Africa Rotavirus Vaccine Market Size, by Community Health Centers, 2017-2032 (USD Million)
TABLE 130. Africa Rotavirus Vaccine Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 131. Global Rotavirus Vaccine Market Size, by Group, 2017-2032 (USD Million)
TABLE 132. ASEAN Rotavirus Vaccine Market Size, by Group, 2017-2032 (USD Million)
TABLE 133. ASEAN Rotavirus Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 134. ASEAN Rotavirus Vaccine Market Size, by Presentation, 2017-2032 (USD Million)
TABLE 135. ASEAN Rotavirus Vaccine Market Size, by Liquid, 2017-2032 (USD Million)
TABLE 136. ASEAN Rotavirus Vaccine Market Size, by Lyophilized, 2017-2032 (USD Million)
TABLE 137. ASEAN Rotavirus Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 138. ASEAN Rotavirus Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 139. ASEAN Rotavirus Vaccine Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 140. ASEAN Rotavirus Vaccine Market Size, by Community Health Centers, 2017-2032 (USD Million)
TABLE 141. ASEAN Rotavirus Vaccine Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 142. GCC Rotavirus Vaccine Market Size, by Group, 2017-2032 (USD Million)
TABLE 143. GCC Rotavirus Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 144. GCC Rotavirus Vaccine Market Size, by Presentation, 2017-2032 (USD Million)
TABLE 145. GCC Rotavirus Vaccine Market Size, by Liquid, 2017-2032 (USD Million)
TABLE 146. GCC Rotavirus Vaccine Market Size, by Lyophilized, 2017-2032 (USD Million)
TABLE 147. GCC Rotavirus Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 148. GCC Rotavirus Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 149. GCC Rotavirus Vaccine Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 150. GCC Rotavirus Vaccine Market Size, by Community Health Centers, 2017-2032 (USD Million)
TABLE 151. GCC Rotavirus Vaccine Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 152. European Union Rotavirus Vaccine Market Size, by Group, 2017-2032 (USD Million)
TABLE 153. European Union Rotavirus Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 154. European Union Rotavirus Vaccine Market Size, by Presentation, 2017-2032 (USD Million)
TABLE 155. European Union Rotavirus Vaccine Market Size, by Liquid, 2017-2032 (USD Million)
TABLE 156. European Union Rotavirus Vaccine Market Size, by Lyophilized, 2017-2032 (USD Million)
TABLE 157. European Union Rotavirus Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 158. European Union Rotavirus Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 159. European Union Rotavirus Vaccine Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 160. European Union Rotavirus Vaccine Market Size, by Community Health Centers, 2017-2032 (USD Million)
TABLE 161. European Union Rotavirus Vaccine Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 162. BRICS Rotavirus Vaccine Market Size, by Group, 2017-2032 (USD Million)
TABLE 163. BRICS Rotavirus Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 164. BRICS Rotavirus Vaccine Market Size, by Presentation, 2017-2032 (USD Million)
TABLE 165. BRICS Rotavirus Vaccine Market Size, by Liquid, 2017-2032 (USD Million)
TABLE 166. BRICS Rotavirus Vaccine Market Size, by Lyophilized, 2017-2032 (USD Million)
TABLE 167. BRICS Rotavirus Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 168. BRICS Rotavirus Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 169. BRICS Rotavirus Vaccine Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 170. BRICS Rotavirus Vaccine Market Size, by Community Health Centers, 2017-2032 (USD Million)
TABLE 171. BRICS Rotavirus Vaccine Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 172. G7 Rotavirus Vaccine Market Size, by Group, 2017-2032 (USD Million)
TABLE 173. G7 Rotavirus Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 174. G7 Rotavirus Vaccine Market Size, by Presentation, 2017-2032 (USD Million)
TABLE 175. G7 Rotavirus Vaccine Market Size, by Liquid, 2017-2032 (USD Million)
TABLE 176. G7 Rotavirus Vaccine Market Size, by Lyophilized, 2017-2032 (USD Million)
TABLE 177. G7 Rotavirus Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 178. G7 Rotavirus Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 179. G7 Rotavirus Vaccine Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 180. G7 Rotavirus Vaccine Market Size, by Community Health Centers, 2017-2032 (USD Million)
TABLE 181. G7 Rotavirus Vaccine Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 182. NATO Rotavirus Vaccine Market Size, by Group, 2017-2032 (USD Million)
TABLE 183. NATO Rotavirus Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 184. NATO Rotavirus Vaccine Market Size, by Presentation, 2017-2032 (USD Million)
TABLE 185. NATO Rotavirus Vaccine Market Size, by Liquid, 2017-2032 (USD Million)
TABLE 186. NATO Rotavirus Vaccine Market Size, by Lyophilized, 2017-2032 (USD Million)
TABLE 187. NATO Rotavirus Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 188. NATO Rotavirus Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 189. NATO Rotavirus Vaccine Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 190. NATO Rotavirus Vaccine Market Size, by Community Health Centers, 2017-2032 (USD Million)
TABLE 191. NATO Rotavirus Vaccine Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 192. Global Rotavirus Vaccine Market Size, by Country, 2017-2032 (USD Million)
TABLE 193. United States Rotavirus Vaccine Market Size, 2017-2032 (USD Million)
TABLE 194. United States Rotavirus Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 195. United States Rotavirus Vaccine Market Size, by Presentation, 2017-2032 (USD Million)
TABLE 196. United States Rotavirus Vaccine Market Size, by Liquid, 2017-2032 (USD Million)
TABLE 197. United States Rotavirus Vaccine Market Size, by Lyophilized, 2017-2032 (USD Million)
TABLE 198. United States Rotavirus Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 199. United States Rotavirus Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 200. United States Rotavirus Vaccine Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 201. United States Rotavirus Vaccine Market Size, by Community Health Centers, 2017-2032 (USD Million)
TABLE 202. United States Rotavirus Vaccine Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 203. Canada Rotavirus Vaccine Market Size, 2017-2032 (USD Million)
TABLE 204. Canada Rotavirus Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 205. Canada Rotavirus Vaccine Market Size, by Presentation, 2017-2032 (USD Million)
TABLE 206. Canada Rotavirus Vaccine Market Size, by Liquid, 2017-2032 (USD Million)
TABLE 207. Canada Rotavirus Vaccine Market Size, by Lyophilized, 2017-2032 (USD Million)
TABLE 208. Canada Rotavirus Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 209. Canada Rotavirus Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 210. Canada Rotavirus Vaccine Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 211. Canada Rotavirus Vaccine Market Size, by Community Health Centers, 2017-2032 (USD Million)
TABLE 212. Canada Rotavirus Vaccine Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 213. Mexico Rotavirus Vaccine Market Size, 2017-2032 (USD Million)
TABLE 214. Mexico Rotavirus Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 215. Mexico Rotavirus Vaccine Market Size, by Presentation, 2017-2032 (USD Million)
TABLE 216. Mexico Rotavirus Vaccine Market Size, by Liquid, 2017-2032 (USD Million)
TABLE 217. Mexico Rotavirus Vaccine Market Size, by Lyophilized, 2017-2032 (USD Million)
TABLE 218. Mexico Rotavirus Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 219. Mexico Rotavirus Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 220. Mexico Rotavirus Vaccine Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 221. Mexico Rotavirus Vaccine Market Size, by Community Health Centers, 2017-2032 (USD Million)
TABLE 222. Mexico Rotavirus Vaccine Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 223. Brazil Rotavirus Vaccine Market Size, 2017-2032 (USD Million)
TABLE 224. Brazil Rotavirus Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 225. Brazil Rotavirus Vaccine Market Size, by Presentation, 2017-2032 (USD Million)
TABLE 226. Brazil Rotavirus Vaccine Market Size, by Liquid, 2017-2032 (USD Million)
TABLE 227. Brazil Rotavirus Vaccine Market Size, by Lyophilized, 2017-2032 (USD Million)
TABLE 228. Brazil Rotavirus Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 229. Brazil Rotavirus Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 230. Brazil Rotavirus Vaccine Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 231. Brazil Rotavirus Vaccine Market Size, by Community Health Centers, 2017-2032 (USD Million)
TABLE 232. Brazil Rotavirus Vaccine Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 233. United Kingdom Rotavirus Vaccine Market Size, 2017-2032 (USD Million)
TABLE 234. United Kingdom Rotavirus Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 235. United Kingdom Rotavirus Vaccine Market Size, by Presentation, 2017-2032 (USD Million)
TABLE 236. United Kingdom Rotavirus Vaccine Market Size, by Liquid, 2017-2032 (USD Million)
TABLE 237. United Kingdom Rotavirus Vaccine Market Size, by Lyophilized, 2017-2032 (USD Million)
TABLE 238. United Kingdom Rotavirus Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 239. United Kingdom Rotavirus Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 240. United Kingdom Rotavirus Vaccine Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 241. United Kingdom Rotavirus Vaccine Market Size, by Community Health Centers, 2017-2032 (USD Million)
TABLE 242. United Kingdom Rotavirus Vaccine Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 243. Germany Rotavirus Vaccine Market Size, 2017-2032 (USD Million)
TABLE 244. Germany Rotavirus Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 245. Germany Rotavirus Vaccine Market Size, by Presentation, 2017-2032 (USD Million)
TABLE 246. Germany Rotavirus Vaccine Market Size, by Liquid, 2017-2032 (USD Million)
TABLE 247. Germany Rotavirus Vaccine Market Size, by Lyophilized, 2017-2032 (USD Million)
TABLE 248. Germany Rotavirus Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 249. Germany Rotavirus Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 250. Germany Rotavirus Vaccine Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 251. Germany Rotavirus Vaccine Market Size, by Community Health Centers, 2017-2032 (USD Million)
TABLE 252. Germany Rotavirus Vaccine Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 253. France Rotavirus Vaccine Market Size, 2017-2032 (USD Million)
TABLE 254. France Rotavirus Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 255. France Rotavirus Vaccine Market Size, by Presentation, 2017-2032 (USD Million)
TABLE 256. France Rotavirus Vaccine Market Size, by Liquid, 2017-2032 (USD Million)
TABLE 257. France Rotavirus Vaccine Market Size, by Lyophilized, 2017-2032 (USD Million)
TABLE 258. France Rotavirus Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 259. France Rotavirus Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 260. France Rotavirus Vaccine Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 261. France Rotavirus Vaccine Market Size, by Community Health Centers, 2017-2032 (USD Million)
TABLE 262. France Rotavirus Vaccine Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 263. Russia Rotavirus Vaccine Market Size, 2017-2032 (USD Million)
TABLE 264. Russia Rotavirus Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 265. Russia Rotavirus Vaccine Market Size, by Presentation, 2017-2032 (USD Million)
TABLE 266. Russia Rotavirus Vaccine Market Size, by Liquid, 2017-2032 (USD Million)
TABLE 267. Russia Rotavirus Vaccine Market Size, by Lyophilized, 2017-2032 (USD Million)
TABLE 268. Russia Rotavirus Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 269. Russia Rotavirus Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 270. Russia Rotavirus Vaccine Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 271. Russia Rotavirus Vaccine Market Size, by Community Health Centers, 2017-2032 (USD Million)
TABLE 272. Russia Rotavirus Vaccine Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 273. Italy Rotavirus Vaccine Market Size, 2017-2032 (USD Million)
TABLE 274. Italy Rotavirus Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 275. Italy Rotavirus Vaccine Market Size, by Presentation, 2017-2032 (USD Million)
TABLE 276. Italy Rotavirus Vaccine Market Size, by Liquid, 2017-2032 (USD Million)
TABLE 277. Italy Rotavirus Vaccine Market Size, by Lyophilized, 2017-2032 (USD Million)
TABLE 278. Italy Rotavirus Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 279. Italy Rotavirus Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 280. Italy Rotavirus Vaccine Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 281. Italy Rotavirus Vaccine Market Size, by Community Health Centers, 2017-2032 (USD Million)
TABLE 282. Italy Rotavirus Vaccine Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 283. Spain Rotavirus Vaccine Market Size, 2017-2032 (USD Million)
TABLE 284. Spain Rotavirus Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 285. Spain Rotavirus Vaccine Market Size, by Presentation, 2017-2032 (USD Million)
TABLE 286. Spain Rotavirus Vaccine Market Size, by Liquid, 2017-2032 (USD Million)
TABLE 287. Spain Rotavirus Vaccine Market Size, by Lyophilized, 2017-2032 (USD Million)
TABLE 288. Spain Rotavirus Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 289. Spain Rotavirus Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 290. Spain Rotavirus Vaccine Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 291. Spain Rotavirus Vaccine Market Size, by Community Health Centers, 2017-2032 (USD Million)
TABLE 292. Spain Rotavirus Vaccine Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 293. China Rotavirus Vaccine Market Size, 2017-2032 (USD Million)
TABLE 294. China Rotavirus Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 295. China Rotavirus Vaccine Market Size, by Presentation, 2017-2032 (USD Million)
TABLE 296. China Rotavirus Vaccine Market Size, by Liquid, 2017-2032 (USD Million)
TABLE 297. China Rotavirus Vaccine Market Size, by Lyophilized, 2017-2032 (USD Million)
TABLE 298. China Rotavirus Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 299. China Rotavirus Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 300. China Rotavirus Vaccine Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 301. China Rotavirus Vaccine Market Size, by Community Health Centers, 2017-2032 (USD Million)
TABLE 302. China Rotavirus Vaccine Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 303. India Rotavirus Vaccine Market Size, 2017-2032 (USD Million)
TABLE 304. India Rotavirus Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 305. India Rotavirus Vaccine Market Size, by Presentation, 2017-2032 (USD Million)
TABLE 306. India Rotavirus Vaccine Market Size, by Liquid, 2017-2032 (USD Million)
TABLE 307. India Rotavirus Vaccine Market Size, by Lyophilized, 2017-2032 (USD Million)
TABLE 308. India Rotavirus Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 309. India Rotavirus Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 310. India Rotavirus Vaccine Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 311. India Rotavirus Vaccine Market Size, by Community Health Centers, 2017-2032 (USD Million)
TABLE 312. India Rotavirus Vaccine Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 313. Japan Rotavirus Vaccine Market Size, 2017-2032 (USD Million)
TABLE 314. Japan Rotavirus Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 315. Japan Rotavirus Vaccine Market Size, by Presentation, 2017-2032 (USD Million)
TABLE 316. Japan Rotavirus Vaccine Market Size, by Liquid, 2017-2032 (USD Million)
TABLE 317. Japan Rotavirus Vaccine Market Size, by Lyophilized, 2017-2032 (USD Million)
TABLE 318. Japan Rotavirus Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 319. Japan Rotavirus Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 320. Japan Rotavirus Vaccine Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 321. Japan Rotavirus Vaccine Market Size, by Community Health Centers, 2017-2032 (USD Million)
TABLE 322. Japan Rotavirus Vaccine Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 323. Australia Rotavirus Vaccine Market Size, 2017-2032 (USD Million)
TABLE 324. Australia Rotavirus Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 325. Australia Rotavirus Vaccine Market Size, by Presentation, 2017-2032 (USD Million)
TABLE 326. Australia Rotavirus Vaccine Market Size, by Liquid, 2017-2032 (USD Million)
TABLE 327. Australia Rotavirus Vaccine Market Size, by Lyophilized, 2017-2032 (USD Million)
TABLE 328. Australia Rotavirus Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 329. Australia Rotavirus Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 330. Australia Rotavirus Vaccine Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 331. Australia Rotavirus Vaccine Market Size, by Community Health Centers, 2017-2032 (USD Million)
TABLE 332. Australia Rotavirus Vaccine Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 333. South Korea Rotavirus Vaccine Market Size, 2017-2032 (USD Million)
TABLE 334. South Korea Rotavirus Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 335. South Korea Rotavirus Vaccine Market Size, by Presentation, 2017-2032 (USD Million)
TABLE 336. South Korea Rotavirus Vaccine Market Size, by Liquid, 2017-2032 (USD Million)
TABLE 337. South Korea Rotavirus Vaccine Market Size, by Lyophilized, 2017-2032 (USD Million)
TABLE 338. South Korea Rotavirus Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 339. South Korea Rotavirus Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 340. South Korea Rotavirus Vaccine Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 341. South Korea Rotavirus Vaccine Market Size, by Community Health Centers, 2017-2032 (USD Million)
TABLE 342. South Korea Rotavirus Vaccine Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 343. Global Rotavirus Vaccine Market Share, by Key Player, 2025
TABLE 344. Global Rotavirus Vaccine Market, Key Experts

Companies Mentioned

  • Bharat Biotech International Limited
  • Bio Farma
  • Biological E. Limited
  • Cadila Healthcare Limited
  • GlaxoSmithKline plc
  • Hilleman Laboratories
  • Indian Immunologicals Limited
  • Lanzhou Institute of Biological Products Co., Ltd.
  • Merck & Co., Inc.
  • Novavax, Inc.
  • Panacea Biotec Ltd.
  • Pfizer Inc.
  • Sanofi S.A.
  • Serum Institute of India Pvt. Ltd.
  • Shantha Biotechnics
  • Sinovac Biotech Ltd.
  • Takeda Pharmaceutical Company Limited
  • Valneva SE

Related Topics

Related Reports

Multivalent Oral Rotavirus Vaccine Market - Global Forecast 2026-2032 - Product Image

Multivalent Oral Rotavirus Vaccine Market - Global Forecast 2026-2032

  • Report
  • 195 Pages
  • Global
From
Pediatric Vaccines Market - Global Forecast 2026-2032 - Product Image

Pediatric Vaccines Market - Global Forecast 2026-2032

  • Report
  • 194 Pages
  • Global
From
Rotavirus Vaccine Market Strategic Outlook & Competitive Landscape (2026-2031) - Product Image

Rotavirus Vaccine Market Strategic Outlook & Competitive Landscape (2026-2031)

  • Report
  • 99 Pages
  • Global
From
Rotavirus Vaccines Market - Global Strategic Business Report - Product Image

Rotavirus Vaccines Market - Global Strategic Business Report

  • Report
  • 277 Pages
  • Global
From
Rotarix Market Report 2026: Epidemiology, Pipeline Analysis, Market Insights & Forecasts - Product Image

Rotarix Market Report 2026: Epidemiology, Pipeline Analysis, Market Insights & Forecasts

  • Report
  • 250 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.